intro to medical micro Flashcards

1
Q

what are the organisms that make up medical microbiology?

A
  • viruses
  • bacteria
  • fungi
  • parasites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

gram + bacteria examples

A
  • staph
  • strep
  • enterococci
  • bacillus
  • cornynebacteria
  • actinomyces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

gram - bacteria examples

A
  • enterobacteriaceae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bacterial morphologies

A
  • cocci
  • bacilli
  • coccobacilli
  • spirochetes
  • comma
  • individual cells, pairs, chains, or clusters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bacterial size (average)

A

1-2µM in diameter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cell envelope structure

A

gram +

  • cytoplasmic (inner) membrane
  • peptidoglycan cell wall

gram -

  • cytoplasmic (inner) membrane
  • peptidoglycan cell wall + periplasm
  • outer membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cell envelope functions

A
  • surround cytosol
  • protect from environmental threats
  • cellular functions that happen in organelles in eukaryotes (like metabolism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cytoplasmic membrane structure

A
  • lipid bilayer
  • integral and peripheral proteins
  • no sterols (except mycoplasma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cytoplasmic membrane function

A
  • permeability barrier
  • ETC
  • export of membrane and secreted proteins
  • cell wall component biosynthesis
  • partitioning of daughter cells during division
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cell wall function

A
  • gives cells shape
  • protection against osmotic lysis
  • mycoplasma does not have a cell wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cell wall structure

A

thick (+) or thin (-) peptidoglycan layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

peptidoglycan structure

A
  • N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) disaccharides linked in long polymers
  • Peptides of alternating L and D AAs extending from sugars
  • Cross-linking of 3rd AA from one peptide to the terminal (usually 4th) AA of another peptide, often via gly residues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

peptidoglycan synthesis

A
  • Penicillin binding proteins add peptide side chains to the sugar polymers and add cross-linking glycines
  • synthesis inhibited by B-lactams and vanco
  • polymer cleaved into NAGA-NAMA disaccharides by lysozyme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

gram stain process and results

A
  1. stain with crystal violet dye
  2. iodine (mordant) cross links crystal violet
  3. alcohol wash decolorizes gram (-)
  4. counterstain with safranin

gram (+) are stained purple
gram (-) are counterstained pink/red

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

teichoic acids

A
  • components of the gram (+) cell envelope
  • long polymers of glycerol phosphate or ribitol phosphate with sugars and AAs
  • attached to cell wall or cytoplasmic membrane (lipoteichoic acids)
  • function: adhesins – help bacteria stick to surfaces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

gram (-) outer membrane structure

A
  • inner leaflet = phospholipids

- outer leaflet = lipopolysaccharide

17
Q

lipopolysaccharide structure

A

inner -> outer

  • Lipid A: phosphorylated diglucosamine with 5-7 saturated fatty acids. Forms a tight barrier.
  • Core polysaccharide: 7-9 sugars (including weird ones like KDO and heptose)
  • O-antigen: polysaccharide chain made of repeating units of 3-5 sugar residues with up to 40 total. Not present in all gram (-). Initially resists complement deposition (serum resistance) but recognized by specific antibodies with repeated exposure
18
Q

physiological effects of LPS for the human host

A

effects caused by lipid A

low dose:

  • fever
  • complement activation
  • stimulation of B cells and MΦ
  • activates acute phase response

high dose:

  • septic shock
  • hypotension
  • circulatory shock
  • disseminated intravascular coagulation
  • multiple organ failure
  • death
19
Q

mechanism of LPS toxicity

A
  1. LPS-binding protein (LBP) binds LPS
  2. Bound complex interacts with monocyte/MΦ CD14 receptors
  3. LBP-CD14 activates TLRs
  4. Pro-inflammatory cytokine production (IL-1B, TNF-a)
  5. Inflammatory response: fever, increased adherence of leukocytes to endothelial surfaces (WBCs move from blood stream to infected tissues), septic shock syndrome